Alkermes plc
ALKS News Today: Stay Updated with the Latest Alkermes plc News in Real Time
Find ALKS news now at Meyka AI. Stay informed with the latest Alkermes plc stocks updates, including price news, market analysis, and expert insights.
Shell PLX ($SHEL) Rises to 3,168.00 GBX Up +19.50 (0.62%) as Shell Reviews India Energy Strategy and Renewable Focus
Shell PLX ($SHEL) has gained fresh attention in global markets after rising to 3,168.00 GBX, up +19.50 points (0.62%). The move reflects growing investor optimism around Shell’s evolving energy strategy. The company is actively reviewing its India energy expansion plans while balancing a stronger push into renewable energy. This combination is shaping how investors view…
Ryanair Holdings Slips 0.99% as Earnings Loom on May 18
RY4C.DE stock falls 0.99% to €22.94 ahead of May 18 earnings announcement. Meyka AI rates the airline with an A grade.
STX: Seagate Officer Sells 2,358 Shares on May 14, 2026
Seagate Technology officer Teh Ban Seng sold 2,358 NQ Options shares at $101.34 on May 14, 2026. SEC filing details insider transaction.
Ryanair Holdings Slips 1.62% Ahead of May 18 Earnings Report
Ryanair (RYA.IR) stock falls 1.62% to €22.46 on EURONEXT ahead of May 18 earnings announcement. Meyka AI rates the airline with a Buy grade.
Datalex plc (DLE.IR) Holds Steady at €0.30 Amid Software Sector Volatility
DLE.IR stock trades flat at €0.30 on EURONEXT. Datalex plc faces headwinds with negative earnings but maintains market position in airline software.
Open Orphan Plc (ORPH.IR) Holds Steady at €0.14 on EURONEXT
ORPH.IR stock trades flat at €0.14 on EURONEXT. Biotech firm specializes in human challenge trials and infectious disease research.
Addex Therapeutics (ADXN.SW) Jumps 6.7% as CNS Drug Pipeline Advances
ADXN.SW stock surges 6.7% to CHF 0.048 on SIX. Addex Therapeutics advances CNS drug programs including Dipraglurant and ADX71149.
BIRK Earnings Miss: Birkenstock Misses EPS, Revenue Flat
Birkenstock (BIRK) missed Q1 2026 EPS estimates at $0.59 vs $0.70 expected. Revenue nearly flat at $714.4M. Stock up 3.2% post-earnings.
HSBC Maintained at Sector Perform by RBC Capital, May 2026
RBC Capital maintained HSBC at Sector Perform with price target raised to 1,275 GBp from 1,200 GBp on May 14, 2026.